Neuropharmacology of emesis and its relevance to anti-emetic therapy. Consensus and controversies

Supportive Care in Cancer

Volumn 6, Issue 3, 1998, Pages 197-203

  Andrews, P L R ^a   Naylor, R J ^b   Joss, R A ^c  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF BRADFORD   (United Kingdom)

^c Kantonsspital ^*  (Switzerland)

Author keywords

Anti emetic therapy; Emesis; Neuropharmacology

Indexed keywords

ANTIEMETIC AGENT; GRANISETRON; ONDANSETRON; SEROTONIN 3 RECEPTOR; TROPISETRON;

ANTIEMETIC ACTIVITY; CANCER CHEMOTHERAPY; CANCER PATIENT; HUMAN; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SEROTONIN BRAIN LEVEL; VOMITING;

ANIMALS; ANTIEMETICS; BRAIN; DIGESTIVE SYSTEM; HUMANS; NEOPLASMS; PALLIATIVE CARE; RECEPTORS, NEUROKININ-1; RECEPTORS, SEROTONIN; VOMITING;

EID: 0031900769     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005200050154     Document Type: Review

References (39)

1. Andrews PLR (1996) The mechanism of emesis induced by chemotherapy and radiotherapy, p 3-24. In: Tonato M (ed) Anti-emetics in the supportive care of patients. (ESO monograph) Springer, Berlin Heidelberg New York
2. Andrews PLR, Bhandari PB (1993) Resinferatoxin, an ultrapotent capsaicin analogue, has anti-emetic properties in the ferret. Neuropharmacology 32:799-806
3. Andrews PLR, Davis CJ (1995) The physiology of emesis induced by anti-cancer therapy. In: Reynolds J, Andrews PLR, Davis CJ (eds) Serotonin and the scientific basis of anti-emetic therapy. Oxford Clinical Communications, Oxford, pp 25-49
4. Andrews PLR, Whitehead SA (1990) Pregnancy sickness. News Physiol Sci 5:5-10
5. Andrews PLR, Rapeport G, Sanger GJ (1988) Neuropharmacology of emesis induced by anti-cancer therapy. Trends Pharmacol Sci 9:334-341
6. Andrews PLR, Bhandari PB, Davis CJ (1992) Plasticity and modulation of the emetic reflex. In: Bianchi AL, Grelot L, Miller AD, King GI (eds) Mechanisms and control of emesis. John Libbey Eurotext, vol 223. INSERM. Paris, pp 275-284
7. Andrews PLR, Quan V, Ogg CS (1995) Ondansetron for symptomatic relief in terminal uraemia. Nephrol Dial Transplant 10:40
8. Beattie WS, Lindblad Z, Buckley ND, Forrest JB (1991) The incidence of postoperative nausea and vomiting in women undergoing laparoscopy is influenced by the day of the menstrual cycle. Can J Anaesth 38:298-302
9. Bruera E, Catz Z, Hooper R, Lentle B, MacDonald W (1987) Chronic nausea and anorexia in advanced cancer patients: a possible role for autonomic dysfunction. J Pain Symptom Manage 2:19-21
10. Costall B, Domeney AM, Naylor RJ, Tattersall FD (1986) 5-Hydroxytryptamine M-receptor antagonism to prevent cisplatin-induced emesis. Neuropharmacology 25:959-961
11. Costall B, Naylor RJ, Owera-Atepo J, Tattersall FD (1989) The responsiveness of the ferret to apomorphine-induced emesis. Br J Pharmacol 96:329P
12. Cubeddu LX, Alfieri AB, Hoffmen IS (1995) Clinical evidence for the involvement of serotonin in acute cytotoxic-induced emesis. In: Reynolds J, Andrews PLR, Davis CJ (eds) Serotonin and the scientific basis of antiemetic therapie. Oxford Clinical Communications, Oxford pp 142-149
13. Cubeddu LX, O'Connor DT, Hoffmann I, Palmer RJ (1995) Plasma chromogranin A marks emesis and serotonin release associated with dacarbazine and nitrogen mustard but not with cyclophosphamide-based chemotherapies. Br J Cancer 72:1033-1038
14. Gardner CJ, Twissel DJ, Dale TJ, Gale JD, Jordan CC, Kilpatrick GJ, Bountra C, Ward P (1995) The broad spectrum anti-emetic activity of the novel non-peptide tachykinin NK-1 receptor antagonist GR 203040. Br J Pharmacol 116:158-163
15. Gonsalves S, Watson JW, Ashton C (1996) Broad spectrum antiemetic effect of CP-122721, a tachykinin NK1 receptor antagonist, in ferrets. Eur J Pharmacol 305:181-185
16. Grelot L, Milano S, Le Stunff H (1995) Does 5HT play a role in the delayed phase of cisplatin-induced emesis? In: Reynolds J, Andrews PLR, Davis CJ (eds) Serotonin and the scientific basis of anti-emetic therapy. Oxford Clinical Communications, Oxford, pp 181-191
17. Kleinerman KB, Deppe SA, Sargent AI (1993) Use of ondansetron for control of projectile vomiting in patients with neurosurgical trauma: two case reports. Ann Pharmacother 27:566-568
18. Lucot JB, Crampton GH (1989) 8-0H-DPAT suppresses vomiting in the cat elicited by motion cisplatin or xylazine. Pharmacol Biochem Behav 33:627-631
19. Matsuki N, Torii Y, Saito H (1993) Effects of iron and desferrioxamine on cisplatin-undiced emesis, further evidence for the role of free radicals. Eur J Pharmacol [Environ Toxicol Pharmacol] 248:329-331
20. Miller AD, Jakus J, Nonaka S (1994) Plasticity of emesis to a 5HT-3 agonist: effect of visceral nerve cuts. Neuroreport 5:986-988
21. Miller AD, Rowley HA, Roberts PL, Kucbarczyk J (1996) Human cortical activity during vestibular and drug-induced nausea detected using MSI. Ann NY Acad Sci 781:670-672
22. Miner WJ, Sanger GJ (1986) Inhibition of cisplatin induced vomiting by selective 5-hydroxytryptamine M-receptor antagonism. Br J Pharmacol 88:497-499
23. Minton AU, Swift N, Lawlor R, Mant C, Henry J (1995) Ipecacuanha-induced emesis - a human model for testing antiemetic drug activity. Clin Pharmacol Ther 54:53-57
24. 2 receptor agonist in Suncus murinus. Br J Pharmacol 114:931
25. Racke K, Schworer H, Kilbinger H (1995) The pharmacology of 5-HT release from enterochromaffin cells. In: Reynolds J, Andrews PLR, Davis CJ (eds) Serotonin and the scientific basis of anti-emetic therapy. Oxford Clinical Communications, Oxford, pp 84-89
26. Reed MD, Marx CM (1994) Ondansetron for treating nausea and vomiting in the poisoned patient. Ann Pharmacother 28:331-333
27. Reynolds DJM, Barber NA, Grahame-Smith DG, Leslie RA (1991) Cisplatin-evoked induction of c-fos protein in the brainstem of the ferret: the effect of cervical vagotomy and the anti-emetic 5HT-3 receptor antagonist granisetron (BRL43694). Brain Res 565:321-236
28. Roila F, Tonato M, Basurto C (1987) Antiemetic activity of high doses of metoclopramide combined with methylprednisolone versus metoclopramide alone in cisplatin treated cancer patients, a randomized double-blind trial of the Italian oncology group for clinical research. J Clin Oncol 5:141-149
29. Rub R, Andrews PLR, Whitehead SA (1992) Vomiting: incidence, causes, ageing and sex. In: Bianchi AL, Grélot L, Miller AD, King GI (eds) Mechanisms and control of emesis. (John Libbey Eurotext, vol 223) INSERM, Paris
30. 1A receptor ligands on copper sulphate-induced emesis in the ferret. Br J Pharmacol 100:99P
31. Rudd J, Naylor RJ (1994) Effects of 5HT-3 receptor antagonists on models of acute and delayed emesis induced by cisplatin in the ferret. Neuropharmacoloay 33:1607-1608
32. Rudd JA, Naylor RJ (1996) An interaction of ondansetron and dexamethasone antagonising cisplatin-induced acute and delayed emesis in the ferret. Br J Pharmacol 118:209-214
33. 1 tachykinin receptor antagonist CP99 994, in antagonising the acute and delayed emesis induced by cisplatin in the ferret. Br J Pharmacol 119:931-936
34. Schworer H, Munke H, Stockmann F (1995) Treatment diarrhea in carcinoid syndrome with ondansetron, tropisetron and clonidine. Am J Gastroenterol 90:645-648
35. Scott RH, Woods AJ, Lacey MJ, Fernando D, Crawford JH, Andrews PLR (1995) An electrophysiological investigation into the effects of cisplatin and the protective effects of dexamethasone on cultured dorsal root ganglion neurones from neonatal rats. NS Arch Pharmacol 352:247-255
36. Tattersall FD, Rycroft W, Hill RG, Hargreaves RJ (1994) Enantioselective inhibition of apomorphine-induced emesis in the ferret by the neurokinin-1 receptor antagonist CP-99 994. Neuropharmacology 33:259-260
37. 4 receptor involvement in emesis. In: Reynolds J, Andrews PLR, Davis CJ (eds) Serotonin and the scientific basis of antiemetic therapy. Oxford Clinical Communications. Oxford, pp 192-199
38. Watson JW, Gonsalves SF, Fossa AA, McLean S, Seeger T, Obach S, Andrews PLR (1995) The anti-emetic effects of CP-99 994 in the ferret and the dog: role of the NK1 receptor. Br J Pharmacol 115:84-94
39. Whitehead SA, Holden WA, Andrews PLR (1992) Pregnancy sickness. In: Bianchi AL, Grelot L, Miller AD, King GL (eds) Mechanisms and control of emesis. Libbey Eurotext, pp 297-306 (Colloque INSERM vol 223)